Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$5.22
-0.57%
Mkt Cap $412.96M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (22 analysts)
$17.33
Range $10.00 – $22.00
Implied Upside
+232.0%
Consensus $17.33 vs current $5.22
NASDAQ·Healthcare·Biotechnology
$5.22
-0.57%
Mkt Cap $412.96M
Buy
5
Hold
0
Sell
0
Price Target (22 analysts)
$17.33
Range $10.00 – $22.00
+232.0%
Consensus $17.33 vs current $5.22